ciprofloxacin has been researched along with Lung Adenocarcinoma in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fawzy, MA | 1 |
| Abu-Baih, RH | 1 |
| Abuo-Rahma, GEA | 1 |
| Abdel-Rahman, IM | 1 |
| El-Sheikh, AAK | 1 |
| Nazmy, MH | 1 |
| Bykowska, A | 1 |
| Komarnicka, UK | 1 |
| Jeżowska-Bojczuk, M | 1 |
| Kyzioł, A | 1 |
2 other studies available for ciprofloxacin and Lung Adenocarcinoma
| Article | Year |
|---|---|
In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian Cancer Cell Lines via Attenuating MAPK Signaling Pathway.
Topics: Adenocarcinoma of Lung; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; | 2023 |
Cu
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt | 2018 |